As of 2025-07-16, the Fair Value of Northwest Biotherapeutics Inc (NWBO) is -0.29 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.27 USD, the upside of Northwest Biotherapeutics Inc is -211.30%.
With the market price of 0.27 USD and our fair value calculation, Northwest Biotherapeutics Inc (NWBO) is not a good investment. Investing in NWBO stocks now will result in a potential loss of 211.30%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -529.82 | 179.13 | -105.03 | -62.60 | -83.78 | -120.42 |
| YoY growth | -2,445.99% | 133.81% | -158.63% | 40.40% | -33.83% | -492.85% |
| Market Cap (mil) | 380.99 |
| P/E | |
| Forward P/E |
| EPS | -0.06 |
| Avg earnings growth rate | -492.85% |
| TTM earnings | -84.81 |